Celcuity Inc. Common Stock (CELC) News
Latest headlines that mention CELC, newest first · each headline opens the original publisher
- Last price
- $65.57
- Day change
- +6.51%
- Next earnings
- 2026-11-11
CELC headlines
latest coverageIts first commercialized drug is now available for qualified patients.
Revtopik launch underway with 80 oncology specialists supporting expansion into first-line treatment.
Celcuity stock crashed Wednesday after the biotech delayed the launch of its just-approved breast cancer treatment until the third quarter. The post Why This Biotech Stock, With Its First FDA Approval, Just Crashed By Double Digits appeared first on Investor's Business Daily .
CELC news alerts
Get an alert by email or push when a new headline mentions CELC.
More news
News headlines aggregated from third-party publishers via public RSS feeds and tagged with the tickers they mention. Frenzy Capital does not publish or endorse the content; clicking a headline opens the original publisher in a new tab.